Industries

Absci and AstraZeneca forge AI partnership to discover cancer treatments

Absci, a frontrunner in generative AI antibody discovery, has partnered with biopharmaceutical giant AstraZeneca to leverage AI in the quest

News Room News Room
- Advertisement -
Ad imageAd image